Usana Health Sciences (USNA) Gross Margin (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Gross Margin data on file, last reported at 76.25% in Q2 2026.

• On a quarterly basis, Gross Margin fell 274.0% year-over-year to 76.25% in Q2 2026; TTM through Apr 2026 was 77.55%, a 298.0% decrease from a year earlier, with the FY2026 full-year figure at 78.29%, down 284.0% from the prior year.
• Gross Margin for Q2 2026 stood at 76.25%, down from 78.16% in the prior quarter.
• Over the last five years, Gross Margin for USNA reached as high as 81.95% in Q4 2024 and fell as low as 76.25% in Q2 2026.
• Historically, Gross Margin has averaged 80.02% across 5 years, with a median of 80.43% in 2023.
• Across the five-year window, Gross Margin surged 123 bps in 2023 and slumped 379 bps in 2026, its largest moves.
• Year by year, Gross Margin stood at 79.63% in 2022, then climbed by 2 bps to 80.86% in 2023, then gained by 1 bps to 81.95% in 2024, then fell by 6 bps to 77.15% in 2025, then dropped by 1 bps to 76.25% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 76.25% in Q2 2026, 78.16% in Q1 2026, and 77.15% in Q3 2025.